Krilogy Financial LLC Abb Vie Inc. Transaction History

Krilogy Financial LLC

$1.29 Billion
Q2 2024

A detailed history of Krilogy Financial LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Krilogy Financial LLC holds 11,161 shares of ABBV stock, worth $2.17 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

11,161

Previous 11,272 0.98%

Holding current value

$2.17 Million

Previous $2.05 Million 6.73%

% of portfolio

0.15%

Previous 0.17%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$154.79 - $180.76 $17,181 - $20,064	-111 Reduced 0.98%	11,161 $1.91 Million
Q1 2024 Apr 24, 2024	BUY	$159.82 - $182.1 $59,293 - $67,559	371 Added 3.4%	11,272 $2.05 Million
Q4 2023 Jan 26, 2024	BUY	$137.6 - $154.97 $1.5 Million - $1.69 Million	10,901 New	10,901 $1.69 Million
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $774,675 - $892,154	-5,357 Reduced 34.8%	10,038 $1.6 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $990,852 - $1.19 Million	7,164 Added 87.04%	15,395 $2.49 Million
Q3 2022 Oct 06, 2022	BUY	$134.21 - $153.93 $50,194 - $57,569	374 Added 4.76%	8,231 $1.11 Million
Q2 2022 Jul 14, 2022	BUY	$137.62 - $174.96 $32,203 - $40,940	234 Added 3.07%	7,857 $1.2 Million
Q1 2022 Apr 28, 2022	BUY	$131.98 - $163.75 $352,914 - $437,867	2,674 Added 54.03%	7,623 $1.24 Million
Q4 2021 Jan 27, 2022	BUY	$107.43 - $135.93 $15,255 - $19,302	142 Added 2.95%	4,949 $670,000
Q3 2021 Oct 25, 2021	BUY	$106.4 - $120.78 $27,132 - $30,798	255 Added 5.6%	4,807 $519,000
Q2 2021 Jul 20, 2021	SELL	$105.21 - $117.21 $44,819 - $49,931	-426 Reduced 8.56%	4,552 $513,000
Q1 2021 Apr 21, 2021	BUY	$102.3 - $112.62 $30,894 - $34,011	302 Added 6.46%	4,978 $539,000
Q4 2020 Feb 11, 2021	SELL	$80.49 - $108.67 $13,441 - $18,147	-167 Reduced 3.45%	4,676 $501,000
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $79,209 - $92,965	922 Added 23.51%	4,843 $424,000
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $31,035 - $41,530	423 Added 12.09%	3,921 $384,000
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $1,612 - $2,444	-25 Reduced 0.71%	3,498 $266,000
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $254,113 - $317,950	3,523 New	3,523 $311,000
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $226,476 - $272,289	-3,596 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $20,301 - $25,949	309 Added 9.4%	3,596 $262,000
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $13,345 - $15,706	173 Added 5.56%	3,287 $265,000
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $70,142 - $86,505	-901 Reduced 22.44%	3,114 $287,000
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $5,512 - $6,128	-62 Reduced 1.52%	4,015 $380,000
Q2 2018 Aug 15, 2018	BUY	$89.78 - $106.23 $95,346 - $112,816	1,062 Added 35.22%	4,077 $378,000
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $19,138 - $25,627	-208 Reduced 6.45%	3,015 $285,000
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $16,389 - $17,972	-183 Reduced 5.37%	3,223 $312,000
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $23,679 - $30,245	339 Added 11.05%	3,406 $303,000
Q2 2017 Aug 15, 2017	BUY	N/A	3,067	3,067 $222,000

Others Institutions Holding ABBV

# of Institutions

3,692

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $343B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.

Account

Krilogy Financial LLC Abb Vie Inc. Transaction History